← Search recalls
FDA (Device enforcement)Recalled 2015-05-07closedclass ii

Roche Diagnostics Operations, Inc.: Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and 400 plus systems, cobas

Is my product affected?

Triglycerides GPO. In vitro test for the quantitative determination of triglycerides in human serum and plasma on the COBAS Integra 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cobas c systems.

  • UPC 04657594190
  • UPC 20767107322
  • UPC 05171407190
  • UPC 11730711216
  • UPC 11876023216
  • UPC 11876040216
  • UPC 11488872216

Check against the official notice below — it lists the full affected range.

What happened

Roche Diagnostics Operations, Inc. is recalling Triglycerides GPO, an in vitro test used with COBAS Integra 800 and 400 plus analyzer systems to measure triglyceride levels in human serum and plasma. The recall affects 6,255 units distributed nationwide in the United States and Puerto Rico across eight specific lot/catalog numbers.

The recall was initiated due to possible drug interference with the Trinder reaction method used in these tests. Test results may be falsely decreased when urine samples are tested using the Creatinine plus and Uric Acid applications, or when blood samples are collected before sufficient time has passed following administration of Acetaminophen or N-acetylcysteine. The source document does not specify a remedy or recommended action for affected consumers.

Written by software from the official notice below. Not reviewed by a lawyer.

Hazard

Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Details from the source

Reason for recall: Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine. Distribution: US (nationwide) including PR. Quantity: 6255 Lot/code info: Catalog Numbers: 04657594190; 20767107322; 05171407190; 20767107322; 11730711216; 11876023216; 11876040216; 11488872216.

Source

Official record: FDA (Device enforcement) ↗

Republished from the official source above; details can change — the source record controls.

Related recalls

All FDA (Device enforcement) recalls

Hurt by this product? Start a free Case Check

ProductRisk is not a law firm and does not provide legal services or legal advice. ProductRisk is a free consumer product-safety information service operated by Plaintify, Inc., a technology company. If you ask to be connected with a law firm, any legal services are provided by that firm — not by ProductRisk or Plaintify.

Privacy · Plaintify